Contact Jacoby & Meyers
Dangerous Drug Lawyers
Call us Today 800-977-5614

Propulsid was a prescription drug designed for the treatment of severe gastroesophageal reflux disease (GERD), more commonly known as acute nighttime heartburn. The drug works by increasing the rate at which your esophagus, stomach and intestines move during digestion. It was approved by the FDA in 1993, and in 1999 sales of Propulsid had reached approximately $950 million. At the drugs peak, it was averaging approximately $1 billion a year. Jansen Pharmaceuticals manufactured Propulsid and the drug was prescribed to nearly 10 million patients.
In 2000, the FDA reported that there were 381 cases of heart rhythm abnormalities and 80 deaths resulting from the use of Propulsid. Later that same year, Propulsid was taken off the market because of these serious risks.
In a study looking at 58,000 premature babies, it was seen that 20% of these infants’ mothers had been given Propulsid during pregnancy. 11 infant deaths were also associated with the drug.
Serious side effects may include:
Less serious side effects may include:
Lawyer Advertising. This website is designed for general information only, and in no way is intended to constitute legal advice nor the formation of a lawyer/client relationship without a signed, written agreement. Testimonials or endorsements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter. You pay no fees or costs unless we recover for you. This website contains dramatizations. Prior results are not a guarantee of a future outcome. Jacoby & Meyers does not accept all cases and works cooperatively with co-counsel and/or other law firms with whom it has joint agreements who might potentially handle your cases. We look forward to helping you with your claim.
© 2012-2025 Jacoby & Meyers. All rights reserved.